Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B4GALT6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | SYNGR2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | CEP170 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | AGPAT5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | CARD17 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | TMEM147 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | SLC35A2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | TBC1D22A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |